propranolol has been researched along with ecopipam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Alam, AM; Starr, MS | 1 |
| Chan, TMV; Clarke, PBS; Rahman, S; Ren, S; Satanove, DJ | 1 |
1 review(s) available for propranolol and ecopipam
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for propranolol and ecopipam
| Article | Year |
|---|---|
D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cerebral Cortex; Colforsin; Dopamine; Dopamine Agents; Epilepsy; Female; Fenoldopam; In Vitro Techniques; Magnesium; Male; Propranolol; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1993 |
Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Benzazepines; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prazosin; Propranolol; Rats; Receptors, Nicotinic; Reinforcement, Psychology | 2021 |